Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe HypertensionNCT07511361KARDPhase 2Recruiting2026-12Estimated
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile InfectionNCT07513285ACXPPhase 2Recruiting2027-09-29Estimated
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLNCT07516093NRIXPhase 3Recruiting2029-10Estimated
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 StudyNCT07516132OCULPhase 3Recruiting2030-08-01Estimated
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent ThalassemiaNCT07517133AGIOPhase 3Recruiting2029-03Estimated
Chinese Adults With Kidney DiseaseNCT07522099ADARx Pharmaceuticals, Inc.Phase 2Recruiting2028-07-10Estimated
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and SafetyNCT07523581ELOXPhase 2Recruiting2027-06-30Estimated
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaNCT07533942Jazz PharmaceuticalsPhase 2Recruiting2028-10-25Estimated
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT07538583Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2027-01-31Estimated
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)NCT07540897Alkermes, Inc.Phase 3Recruiting2027-06Estimated
A Study of JADE101 in Participants With Immunoglobulin A NephropathyNCT07541287JBIOPhase 2Recruiting2029-01Estimated
A Clinical Study Evaluating Licaminlimab for Dry Eye DiseaseNCT07548632OculisPhase 2, Phase 3Recruiting2026-12Estimated
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)NCT07552077PVLAPhase 2Recruiting2027-08Estimated
ALTO-207 in Adults With Treatment-resistant Depression (TRD)NCT07553637Alto NeurosciencePhase 2Recruiting2027-11Estimated
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy VolunteersNCT07560150AMPHPhase 2, Phase 3Completed2026-06-22Actual
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposureNCT07562087TARSPhase 2Active not recruiting2027-10Estimated
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaNCT07562152Immuneering CorporationPhase 3Recruiting2028-06Estimated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1NCT07563881RAPPPhase 3Recruiting2029-07Estimated
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsNCT07565428Minerva NeurosciencesPhase 3Recruiting2027-12Estimated
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host DiseaseNCT07568535MESOPhase 3Not yet recruiting2028-02-28Estimated
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654COMPASS PathwaysPhase 2, Phase 3Recruiting2028-11Estimated
NAI for Sepsis With Persistent LymphopeniaNCT07578558IBRXPhase 2Not yet recruiting2027-08-03Estimated
Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2NCT07579351Semnur Pharmaceuticals, Inc.Phase 3Not yet recruiting2028-11Estimated
Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)NCT07579910Spruce BiosciencesPhase 3Not yet recruiting2033-08Estimated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689Definium Therapeutics US, Inc.Phase 3Recruiting2027-09Estimated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresNCT07594119RAPPPhase 3Recruiting2029-07Estimated
A Study to Assess the Safety, Tolerability and Efficacy of ION775NCT07604974IONSPhase 2Recruiting2027-09Estimated
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)NCT07608432Dyne TherapeuticsPhase 3Recruiting2030-12Estimated
A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory FailureNCT07615010MiNK TherapeuticsPhase 2Recruiting2027-06Estimated
Study of EVO756 in Adults With MigraineNCT07616128EVMNPhase 2Recruiting2027-10Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.